- Home
- SKWD vs TMDX Comparison
SKWD vs TMDX Comparison
Compare SKWD & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKWD
- TMDX
- Stock Information
- Founded
- SKWD 2007
- TMDX 1998
- Country
- SKWD United States
- TMDX United States
- Employees
- SKWD N/A
- TMDX N/A
- Industry
- SKWD Property-Casualty Insurers
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SKWD Finance
- TMDX Health Care
- Exchange
- SKWD Nasdaq
- TMDX Nasdaq
- Market Cap
- SKWD 2.0B
- TMDX 2.3B
- IPO Year
- SKWD 2023
- TMDX 2019
- Fundamental
- Price
- SKWD $54.79
- TMDX $88.24
- Analyst Decision
- SKWD Buy
- TMDX Buy
- Analyst Count
- SKWD 12
- TMDX 10
- Target Price
- SKWD $59.13
- TMDX $118.44
- AVG Volume (30 Days)
- SKWD 521.7K
- TMDX 1.1M
- Earning Date
- SKWD 05-01-2025
- TMDX 04-29-2025
- Dividend Yield
- SKWD N/A
- TMDX N/A
- EPS Growth
- SKWD 27.90
- TMDX N/A
- EPS
- SKWD 2.87
- TMDX 1.01
- Revenue
- SKWD $1,150,200,000.00
- TMDX $441,540,000.00
- Revenue This Year
- SKWD $16.85
- TMDX $25.33
- Revenue Next Year
- SKWD $12.65
- TMDX $20.53
- P/E Ratio
- SKWD $19.09
- TMDX $87.37
- Revenue Growth
- SKWD 29.82
- TMDX 82.74
- 52 Week Low
- SKWD $33.27
- TMDX $55.00
- 52 Week High
- SKWD $55.62
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- SKWD 61.43
- TMDX 70.61
- Support Level
- SKWD $53.33
- TMDX $82.62
- Resistance Level
- SKWD $52.85
- TMDX $88.48
- Average True Range (ATR)
- SKWD 2.70
- TMDX 5.48
- MACD
- SKWD 0.22
- TMDX 1.98
- Stochastic Oscillator
- SKWD 94.31
- TMDX 99.09
About SKWD Skyward Specialty Insurance Group Inc.
Skyward Specialty Insurance Group Inc is a specialty insurance company that delivers commercial property and casualty products and solutions on a non-admitted and admitted basis. The firm has one reportable segment through which it offers a broad array of insurance coverages to several market niches. It operates multiple lines of business, including general liability, excess liability, professional liability, commercial auto, group accident, health, property, surety, and workers' compensation.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.